Inventor · disambiguated record
Michael P. Zawistoski
Also filed as: ZAWISTOSKI MICHAEL P · ZAWISTOSKI MICHAEL PAUL
7 granted patents·3 pending applications·46 citations·filing 1998–2021
83Inventor score
Top patents by PatentIndex Score
10 records- 0194US9771327B2Compounds and methods for the treatment of cystic fibrosisFLATLEY DISCOVERY LAB LLC·Filed 2014·Granted Sep 26, 2017·14 cites·37 claims
- 0283US10072017B2Compounds and methods for the treatment of cystic fibrosisFLATLEY DISCOVERY LAB LLC·Filed 2016·Granted Sep 11, 2018·5 cites·19 claims
- 0381US6608203B2Tetrahydroisoquinoline compounds as estrogen agonists/antagonistsPFIZER·Filed 2000·Granted Aug 19, 2003·13 cites·57 claims
- 0473US6867202B1Treatment of insulin resistancePFIZER·Filed 2003·Granted Mar 15, 2005·7 cites·8 claims
- 0566US6630487B2Treatment of insulin resistance with growth hormone secretagoguesPFIZER·Filed 2002·Granted Oct 7, 2003·3 cites·7 claims
- 0665US9944603B2Compounds and methods for the treatment of cystic fibrosisFLATLEY DISCOVERY LAB LLC·Filed 2017·Granted Apr 17, 2018·0 cites·2 claims
- 0755US2023055237A1Compounds and methods for the treatment of cystic fibrosisFLATLEY DISCOVERY LAB LLC·Filed 2021·Application pending·0 cites
- 0854US2004192685A1Tetrahydroisoquinoline compounds as estrogen agonists/antagonistsFiled 2004·Application pending·0 cites
- 0952US2003220494A1Tetrahydroisoquinoline compounds as estrogen agonists/antagonistsFiled 2003·Application pending·0 cites
- 1043US6448263B1Treatment of insulin resistance with growth hormone secretagoguesPFIZER·Filed 1998·Granted Sep 10, 2002·4 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →